Healthcare • Medical Instruments & Supplies
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ALC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
82 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
632 filers reported a long position in ALC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $994.6M | 14.7M | -0.8% |
| Bank of New York Mellon Corp | $876.2M | 13.1M | -16.7% |
| NORGES BANK | $741.4M | 11M | — |
| Invesco Ltd. | $696.5M | 10.4M | +2,786.3% |
| AKO CAPITAL LLP | $651.9M | 9.7M | +3.8% |
| Aristotle Capital Management, LLC | $614.3M | 9.2M | -5.8% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $535.8M | 7.9M | -1.3% |
| FMR LLC | $514.2M | 7.7M | -38.3% |
| UBS Group AG | $480.2M | 7.2M | +20.6% |
| Amundi | $445.4M | 6.6M | +16.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.